Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2011-06-21
2011-06-21
Mertz, Prema (Department: 1646)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S001100, C514S021200
Reexamination Certificate
active
07964565
ABSTRACT:
In one aspect the present invention provides methods for inhibiting cell death or inflammation in a mammal, wherein the methods each include the step of administering to a mammal a Bcl protein in an amount sufficient to inhibit cell death or inflammation in the mammal. The invention also provides methods for identifying a Bcl protein that inhibits cell death or inflammation when administered to a mammal.
REFERENCES:
patent: 5523393 (1996-06-01), Tsujimoto et al.
patent: 2003/0176671 (2003-09-01), Reed et al.
patent: 1241254 (2002-09-01), None
patent: WO 97/30083 (1997-08-01), None
patent: WO2004039956 (2004-05-01), None
Cao, Y-J. et al., “Liposome-Mediated Transfer of the bcl-2 Gene Results in Neuroprotection After in Vivo Transient Focal Cerebral Ischemia in an Animal Model,” Gene Therapy, 2002, pp. 415-419, vol. 9.
Coopersmith, C.M. et al., “Overexpression of Bcl-2 in the Intestinal Epithelium Improves Survival in Septic Mice,” Crit. Care Med., 2002, pp. 195-201, vol. 30, No. 1.
PCT International Search Report and Written Opinion, PCT/US05/35666, Mar. 6, 2007, 8 pages.
Cantara, S. et al., “Exogenous BH4/Bcl-2 Peptide Reverts Coronary Endothelial Cell Apoptosis Induced by Oxidative Stress,” Journal of Vascular Research, Mar. 19, 2004, pp. 202-207, vol. 41.
Chen, Z. et al., “Overexpression of Bcl-2 Attenuates Apoptosis and Protects Against Myocardial I/R Injury in Transgenic Mice,” Am. J. Physiol. Heart Circ. Physiol., 2001, pp. H2313-H2320, vol. 280.
Chinese Office Action, Chinese Application No. 200580041661.8, Jul. 10, 2009, 15 pages.
European Extended Search Report, European Application No. 05802454, Oct. 6, 2009, 12 pages.
Hockenbery, D.M. et al., “Bcl-2 Functions in an Antioxidant Pathway to Prevent Apoptosis,” Cell, Oct. 22, 1993, pp. 241-251, vol. 75, No. 2, Cell Press, Cambridge, MA, US.
Hockenbery, D.M. et al., “Bcl-2 is an Inner Mitrochondrial Membrane Protein that Blocks Programmed Cell Death,” Nature, Nov. 22, 1990, pp. 334-336, vol. 348, No. 6299, Nature Publishing Group, London, UK.
Iwata, A. et al., “Over-Expression of Bcl-2 Provides Protection in Septic Mice by a Trans Effect,” Journal of Immunology, Sep. 15, 2003, pp. 3136-3141, vol. 171, No. 6.
Ono, M. et al., “BH4 Peptide Derivative from Bcl-xL Attenuates Ischemia/Reperfusion Injury Through Anti-Apoptotic Mechanism in Rat Hearts,” European Journal of Cardio-Thoracic Surgery, Jan. 2005, pp. 117-121, vol. 27, Issue 1.
Reynolds, J.E. et al., “BCL-2 and MCL-1 Expression in Chinese Hamster Ovary Cells Inhibits Intracellular Acidification and Apoptosis Induced by Staurosporine,” Experimental Cell Research, 1996, pp. 430-436, vol. 225, No. 2.
Rocha, E., “The BH4 Domain of A1, an Anti-Apoptotic bcl Family Gene, is Necessary and Sufficient for its Antiinflammatory Function in Endothelial Cells,” Transplantation Proceedings, 2001, p. 314, vol. 33.
Sentman, C.L. et al., “Bcl-2 Inhibits Multiple Forms of Apoptosis but not Negative Selection in Thymocytes,” Cell, Nov. 29, 1991, pp. 879-888, vol. 67, No. 5, Cell Press, Cambridge, MA, US.
Stroka, D. M. et al., “Overexpression of A1, an NFκB-Inducible Anti-Apoptotic Bcl Gene, Inhibits Endothelial Cell Activation,” Blood, Jun. 11, 1999, pp. 3803-3810, vol. 93, No. 11.
Adams, J.M. et al., “The Bcl-2 Protein Family: Arbiters of Cell Survival,” Science, 1998, pp. 1322-1326, vol. 281.
Australian Examiner's First Report, Australian Application No. 2005294453, Apr. 15, 2009, 2 pages.
Australian Examiner's Second Report, Australian Application No. 2005294453, Nov. 10, 2010, 2 pages.
Boise, L.H. et al., “bcl-x, abcl-2-Related Gene That Functions as a Dominant Regulator of Apoptotic Cell Death,” Cell, Aug. 27, 1993, pp. 597-608, vol. 74.
Cory, S. et al., “The Bcl-2 Family: Roles in Cell Survival and Oncogenesis,” Oncogene, 2003, pp. 8590-8607, vol. 22.
Choi, S.S. et al., “Bfl-1, a Bcl-2-related Gene, is the Human Homolog of the MurineA1, and Maps to Chromosome 15q24.3,” Mammalian Genome, 1997, pp. 781-782, vol. 8.
D'Sa-Eipper, C. et al., “Functional Dissection ofBfl-1, aBcl-2Homolog: Anti-Apoptis, Oncogene-Cooperation and Cell Proliferation Activities,” Oncogene, 1998, pp. 3105-3114, vol. 16.
Gibson, L. et al., “bcl-w, a Novel Member of thebcl-2Family, Promotes Cell Survival,” Oncogene, 1996, pp. 665-675, vol. 13.
Karsan, A. et al., “Cloning of Human Bcl-2 Homologue: Inflammatory Cytokines Induce Human A1 in Cultured Endothelial Cells,” Blood, Apr. 15, 1996, pp. 3089-3096, vol. 87, No. 8.
Lee, L.C. et al., Evidence for α-Helical Conformation of an Essential N-terminal Region in the Human Bcl2 Protein, The Journal of Biological Chemistry, Sep. 20, 1996, pp. 23284-23288, vol. 271, No. 38.
Lin, E.Y. et al., Characterization of A1, a Novel Hemopoietic-Specific Early-Response Gene with Sequence Similarity tobcl-21, The Journal of Immunology, Aug. 15, 1993, pp. 1979-1988, vol. 151.
Werner, A.B. et al., “Bcl-2 Family Member Bfl-1/A1 Sequesters Truncated Bid to Inhibit Its Collaboration with Pro-apoptotic Bak or Bax,” The Journal of Biological Chemistry, Jun. 21, 2002, pp. 22781-22788, vol. 277, No. 25.
Zhang, H. et al., “Structural Basis of BFL-1 for Its Interaction with BAX and Its Antiapoptotic Action in Mammalian and Yeast Cells,” The Journal of Biological Chemistry, Apr. 14, 2000, pp. 11092-11099, vol. 275, No. 15.
European Examination Report, European Application No. 05802454.8, Apr. 7, 2011, 6 pages.
Harlan John M.
Iwata Akiko
Li John
Tupper Joan
Winn Robert K.
Fenwick & West LLP
Mertz Prema
University of Washington Center for Commercialization, a Public
LandOfFree
Method of inhibiting inflammation in a mammal by... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of inhibiting inflammation in a mammal by..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inhibiting inflammation in a mammal by... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2700720